Naert et al. showed that an impairment of Ccr2−/− monocyte trafficking to the brain results in increased levels of intracellular Aβ as well as worsening of cognitive impairment in APP/PS1 mice (58), suggesting the overall protective role of CCR2+ monocytes in AD. The gene discussed is APP; the disease is Alzheimer disease.